Santen Pharmaceutical Reports Q2 Revenue Growth and Increased Net Profit
Santen Pharmaceutical Co., Ltd. has reported its second-quarter financial results, demonstrating steady growth across key metrics. The company achieved a revenue of ¥143.3 billion, marking a 3.9% increase compared to the same period last year. Profitability also saw upward momentum, with core operating profit rising 7.3% year-over-year to ¥23.9 billion. Net profit attributable to owners grew by 10.8%, reaching ¥15.4 billion, while GAAP EPS under IFRS was recorded at ¥48.00.
Tickers: $SNPHY
Topics: earnings report net profit operating profit revenue growth
Read the full article at Seeking Alpha
Part of the story State Bank of India Reports 14.28% Year-on-Year Net Profit Growth in Q2 (2 articles)